It would be better to ask the company about what is taking so long with those latest O+G testing results. Shouldn't we have heard by now? They were supposed to be the ABSOLUTE FINAL END OF TESTING.
I don't see any sense in critiquing the IR guys since the only things that will move this stock are REVENUE PRODUCING SIGNED CONTRACTS!!!--or Grieco's replacement.
I've been LONG here 3 years now, and I'm still waiting on some hopeful revenues from the UK-National Health Service.
I'll guess I'll stick around to the end of 2022 to see if anything develops.